MANKIND PHARMA
Back to Balance Sheet
|
MANKIND PHARMA Last 5 Year Total Assets History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Assets | ₹11,883 Cr | ₹9,686 Cr | ₹9,108 Cr | ₹6,324 Cr | ₹5,025 Cr |
What is the latest Total Assets ratio of MANKIND PHARMA ?
Year | Total Assets |
---|---|
Mar2024 | ₹11,883 Cr |
Mar2023 | ₹9,686 Cr |
Mar2022 | ₹9,108 Cr |
Mar2021 | ₹6,324 Cr |
Mar2020 | ₹5,025 Cr |
How is Total Assets of MANKIND PHARMA Trending?
Years | Total Assets | % Change | |
---|---|---|---|
Mar2024 | ₹11,883 Cr | 22.68 | |
Mar2023 | ₹9,686 Cr | 6.34 | |
Mar2022 | ₹9,108 Cr | 44.04 | |
Mar2021 | ₹6,324 Cr | 25.83 | |
Mar2020 | ₹5,025 Cr | - |
Compare Total Assets of peers of MANKIND PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
MANKIND PHARMA | ₹102,725.5 Cr | 0.5% | 5.6% | 32.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹416,321.0 Cr | -3.5% | -8.8% | 46% | Stock Analytics | |
DIVIS LABORATORIES | ₹158,049.0 Cr | -0.8% | 2.5% | 62.8% | Stock Analytics | |
CIPLA | ₹120,564.0 Cr | 0.4% | -0.7% | 27.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹99,512.9 Cr | -1.8% | -9.1% | 6.4% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹95,426.2 Cr | -0% | -5.8% | 50.7% | Stock Analytics |
MANKIND PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
MANKIND PHARMA | 0.5% |
5.6% |
32.2% |
SENSEX | 2.5% |
-0.5% |
19.7% |
You may also like the below Video Courses